Eurofins Scientific Acquires Infinity Laboratories
September 16, 2024
Eurofins Scientific has completed the acquisition of Infinity Laboratories, a U.S.-based contract testing group that operates eight laboratories and employs approximately 100 staff. The deal expands Eurofins' microbiology and package testing footprint across the United States, enhancing its BioPharma and Medical Device testing capabilities and geographic coverage.
- Buyers
- Eurofins Scientific
- Targets
- Infinity Laboratories, Inc.
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Eurofins Scientific Acquires Element's North American Life Sciences Testing Services Business
July 20, 2026
Healthcare Services
Eurofins Scientific agreed to acquire Element Materials Technology's North American Life Sciences Testing Services business for an enterprise value of $400 million. The business, which operates 27 laboratories and facilities and employs approximately 750 people, provides biopharmaceutical, environmental, and food testing; the acquisition closed on October 1, 2026.
-
Eurofins Agrees to Acquire SYNLAB’s Clinical Diagnostics Operations in Spain
October 28, 2024
Healthcare Services
Eurofins Scientific has reached an agreement with SYNLAB to acquire SYNLAB’s clinical diagnostics operations in Spain. The deal is subject to regulatory approvals and is expected to close in 2025.
-
Eurofins Scientific S.E. Acquires Labormar in Colombia
July 8, 2024
Healthcare Services
Eurofins Scientific S.E. has completed the acquisition of Labormar, a Barranquilla-based laboratory, expanding Eurofins' testing capabilities and presence in Colombia and Latin America. Labormar, now operating as Eurofins Labormar, brings ~90 employees across a laboratory and nine logistics/sampling hubs serving food, feed, cosmetic, pharmacological and environmental testing markets.
-
Eurofins Discovery Acquires DiscoveryBioMed
July 5, 2022
Biotechnology
Eurofins Discovery has acquired DiscoveryBioMed, a Birmingham, Alabama–based contract research organization specializing in human primary- and immortalized-cell based bioassays. The acquisition strengthens Eurofins Discovery’s translational biology and human cell assay capabilities to expand its drug discovery services portfolio.
-
Eurofins Scientific Acquires Genetic Lab Co.,Ltd. (G Lab) in Japan
December 10, 2021
Healthcare Services
Eurofins Scientific has entered into a share purchase agreement to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology-based testing provider in Japan. The acquisition is intended to strengthen Eurofins’ expansion in Asia and enhance its clinical and genetic testing capabilities, including COVID-19 PCR testing and biomarker development support for drug discovery and companion drugs.
-
Eurofins Scientific Acquires bioskin GmbH
August 4, 2021
Healthcare Services
Eurofins Scientific has completed the acquisition of bioskin GmbH, a Hamburg-based dermatology-focused CRO that provides clinical trials for drugs, medical devices, food supplements and advanced cosmetics. The deal expands Eurofins' clinical study management and dermatology capabilities in Germany and strengthens its Cosmetics & Personal Care testing offering.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.